Synthetic prions and other human neurodegenerative proteinopathies

Virus Research

Volumn 207, Issue , 2015, Pages 25-37

  Le, Nhat Tran Thanh ^a   Narkiewicz, Joanna ^a   Aulić, Suzana ^a   Salzano, Giulia ^a   Tran, Hoa Thanh ^a   Scaini, Denis ^b   Moda, Fabio ^c   Giachin, Gabriele ^a   Legname, Giuseppe ^a,d  

^a SISSA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d SINCROTRONE TRIESTE   (Italy)

Author keywords

Neurodegenerative disorders; Prions; Protein misfolding diseases; Strains; Structural biology; Synthetic prions

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; PRION PROTEIN; TAU PROTEIN; PRION; PROTEIN;

ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL SPREADING; CLINICAL FEATURE; DEGENERATIVE DISEASE; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; HUMAN; HYPOTHESIS; INTERNALIZATION; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN ANALYSIS; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; REAL TIME QUAKING INDUCED CONVERSION; VIRAL PHENOMENA AND FUNCTIONS; VIROGENESIS; VIRUS DETECTION; VIRUS STRAIN; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; PROTEIN FOLDING; SYNTHESIS;

ANIMALIA;

ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; PRIONS; PROTEIN FOLDING; PROTEINS;

EID: 84938588011     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.10.020     Document Type: Article

References (138)

1. Abskharon R.N., Giachin G., Wohlkonig A., Soror S.H., Pardon E., Legname G., Steyaert J. Probing the N-terminal beta-sheet conversion in the crystal structure of the human prion protein bound to a nanobody. J. Am. Chem. Soc. 2014, 136(3):937-944.
2. Aguzzi A., Heikenwalder M., Polymenidou M. Insights into prion strains and neurotoxicity. Nat. Rev. Mol. Cell Biol. 2007, 8(7):552-561.
3. Aguzzi A., Heikenwalder M., Polymenidou M. Mechanisms of disease - insights into prion strains and neurotoxicity. Nat. Rev. Mol. Cell Biol. 2007, 8(7):552-561.
4. Amenitsch H., Benetti F., Ramos A., Legname G., Requena J.R. SAXS structural study of PrP reveals ~11nm diameter of basic double intertwined fibers. Prion 2013, 7(6).
5. Atarashi R., Satoh K., Sano K., Fuse T., Yamaguchi N., Ishibashi D., Matsubara T., Nakagaki T., Yamanaka H., Shirabe S., Yamada M., Mizusawa H., Kitamoto T., Klug G., McGlade A., Collins S.J., Nishida N. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat. Med. 2011, 17(2):175-178.
6. Atarashi R., Wilham J.M., Christensen L., Hughson A.G., Moore R.A., Johnson L.M., Onwubiko H.A., Priola S.A., Caughey B. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods 2008, 5(3):211-212.
7. Aulic S., Le T.T., Moda F., Abounit S., Corvaglia S., Casalis L., Gustincich S., Zurzolo C., Tagliavini F., Legname G. Defined alpha-synuclein prion-like molecular assemblies spreading in cell culture. BMC Neurosci. 2014, 15(1):69.
8. Baker H.F., Ridley R.M., Duchen L.W., Crow T.J., Bruton C.J. Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. Int. J. Exp. Pathol. 1993, 74(5):441-454.
9. Barria M.A., Mukherjee A., Gonzalez-Romero D., Morales R., Soto C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog. 2009, 5(5):e1000421.
10. Baskakov I.V., Legname G., Baldwin M.A., Prusiner S.B., Cohen F.E. Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem. 2002, 277(24):21140-21148.
11. Benetti F., Legname G. De novo mammalian prion synthesis. Prion 2009, 3(4):213-219.
12. Bessen R.A., Kocisko D.A., Raymond G.J., Nandan S., Lansbury P.T., Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995, 375(6533):698-700.
13. Bocharova O.V., Makarava N., Breydo L., Anderson M., Salnikov V.V., Baskakov I.V. Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core. J. Biol. Chem. 2006, 281(4):2373-2379.
14. Bousset L., Pieri L., Ruiz-Arlandis G., Gath J., Jensen P.H., Habenstein B., Madiona K., Olieric V., Bockmann A., Meier B.H., Melki R. Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 2013, 4:2575.
15. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24(2):197-211.
16. Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 2004, 27:723-749.
17. Caiati M.D., Safiulina V.F., Fattorini G., Sivakumaran S., Legname G., Cherubini E. PrPC controls via protein kinase A the direction of synaptic plasticity in the immature hippocampus. J. Neurosci. 2013, 33(7):2973-2983.
18. Castilla J., Saa P., Hetz C., Soto C. In vitro generation of infectious scrapie prions. Cell 2005, 121(2):195-206.
19. Caughey B., Raymond G.J., Bessen R.A. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem. 1998, 273(48):32230-32235.
20. Caughey B.W., Dong A., Bhat K.S., Ernst D., Hayes S.F., Caughey W.S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991, 30(31):7672-7680.
21. Chia R., Tattum M.H., Jones S., Collinge J., Fisher E.M., Jackson G.S. Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS ONE 2010, 5(5):e10627.
22. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001, 2(11):806-819.
23. Cobb N.J., Sonnichsen F.D., McHaourab H., Surewicz W.K. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(48):18946-18951.
24. Colby D.W., Giles K., Legname G., Wille H., Baskakov I.V., DeArmond S.J., Prusiner S.B. Design and construction of diverse mammalian prion strains. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(48):20417-20422.
25. Colby D.W., Wain R., Baskakov I.V., Legname G., Palmer C.G., Nguyen H.O., Lemus A., Cohen F.E., DeArmond S.J., Prusiner S.B. Protease-sensitive synthetic prions. PLoS Pathog. 2010, 6(1):e1000736.
26. Colby D.W., Zhang Q., Wang S., Groth D., Legname G., Riesner D., Prusiner S.B. Prion detection by an amyloid seeding assay. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(52):20914-20919.
27. Collinge J., Clarke A.R. A general model of prion strains and their pathogenicity. Science 2007, 318(5852):930-936.
28. Danzer K.M., Haasen D., Karow A.R., Moussaud S., Habeck M., Giese A., Kretzschmar H., Hengerer B., Kostka M. Different species of alpha-synuclein oligomers induce calcium influx and seeding. J. Neurosci. 2007, 27(34):9220-9232.
29. Danzer K.M., Krebs S.K., Wolff M., Birk G., Hengerer B. Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J. Neurochem. 2009, 111(1):192-203.
30. de Calignon A., Polydoro M., Suarez-Calvet M., William C., Adamowicz D.H., Kopeikina K.J., Pitstick R., Sahara N., Ashe K.H., Carlson G.A., Spires-Jones T.L., Hyman B.T. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012, 73(4):685-697.
31. De Genst E.J., Guilliams T., Wellens J., O'Day E.M., Waudby C.A., Meehan S., Dumoulin M., Hsu S.T., Cremades N., Verschueren K.H., Pardon E., Wyns L., Steyaert J., Christodoulou J., Dobson C.M. Structure and properties of a complex of alpha-synuclein and a single-domain camelid antibody. J. Mol. Biol. 2010, 402(2):326-343.
32. De Meyer T., Muyldermans S., Depicker A. Nanobody-based products as research and diagnostic tools. Trends Biotechnol. 2014, 32(5):263-270.
33. Deleault N.R., Harris B.T., Rees J.R., Supattapone S. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(23):9741-9746.
34. Deleault N.R., Lucassen R.W., Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003, 425(6959):717-720.
35. Deleault N.R., Piro J.R., Walsh D.J., Wang F., Ma J., Geoghegan J.C., Supattapone S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(22):8546-8551.
36. Deleault N.R., Walsh D.J., Piro J.R., Wang F., Wang X., Ma J., Rees J.R., Supattapone S. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(28):E1938-E1946.
37. DeMarco M.L., Daggett V. From conversion to aggregation: protofibril formation of the prion protein. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(8):2293-2298.
38. Desplats P., Lee H.J., Bae E.J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., Lee S.J. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(31):13010-13015.
39. Fiala M., Chattopadhay M., La Cava A., Tse E., Liu G., Lourenco E., Eskin A., Liu P.T., Magpantay L., Tse S., Mahanian M., Weitzman R., Tong J., Nguyen C., Cho T., Koo P., Sayre J., Martinez-Maza O., Rosenthal M.J., Wiedau-Pazos M. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J. Neuroinflamm. 2010, 7:76.
40. Frost B., Jacks R.L., Diamond M.I. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 2009, 284(19):12845-12852.
41. Gambetti P., Puoti G., Zou W.Q. Variably protease-sensitive prionopathy: a novel disease of the prion protein. J. Mol. Neurosci. 2011, 45(3):422-424.
42. Gasset M., Baldwin M.A., Fletterick R.J., Prusiner S.B. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(1):1-5.
43. Geoghegan J.C., Valdes P.A., Orem N.R., Deleault N.R., Williamson R.A., Harris B.T., Supattapone S. Selective incorporation of polyanionic molecules into hamster prions. J. Biol. Chem. 2007, 282(50):36341-36353.
44. Ghaemmaghami S., Colby D.W., Nguyen H.O., Hayashi S., Oehler A., DeArmond S.J., Prusiner S.B. Convergent replication of mouse synthetic prion strains. Am. J. Pathol. 2013, 182(3):866-874.
45. Ghaemmaghami S., Watts J.C., Nguyen H.O., Hayashi S., DeArmond S.J., Prusiner S.B. Conformational transformation and selection of synthetic prion strains. J. Mol. Biol. 2011, 413(3):527-542.
46. Goold R., McKinnon C., Rabbanian S., Collinge J., Schiavo G., Tabrizi S.J. Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane. J. Cell Sci. 2013, 126(Pt 16):3552-3562.
47. Goold R., Rabbanian S., Sutton L., Andre R., Arora P., Moonga J., Clarke A.R., Schiavo G., Jat P., Collinge J., Tabrizi S.J. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat. Commun. 2011, 2:281.
48. Goormaghtigh E., Cabiaux V., Ruysschaert J.M. Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur. J. Biochem. 1990, 193(2):409-420.
49. Govaerts C., Wille H., Prusiner S.B., Cohen F.E. Evidence for assembly of prions with left-handed beta-helices into trimers. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(22):8342-8347.
50. Guo J.L., Covell D.J., Daniels J.P., Iba M., Stieber A., Zhang B., Riddle D.M., Kwong L.K., Xu Y., Trojanowski J.Q., Lee V.M. Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 2013, 154(1):103-117.
51. Guo J.L., Lee V.M. Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J. Biol. Chem. 2011, 286(17):15317-15331.
52. Head M.W., Ironside J.W. Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol. Appl. Neurobiol. 2012, 38(4):296-310.
53. Heise H. Solid-state NMR spectroscopy of amyloid proteins. Chembiochem 2008, 9(2):179-189.
54. Helmus J.J., Surewicz K., Nadaud P.S., Surewicz W.K., Jaroniec C.P. Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(17):6284-6289.
55. Herms J., Tings T., Gall S., Madlung A., Giese A., Siebert H., Schurmann P., Windl O., Brose N., Kretzschmar H. Evidence of presynaptic location and function of the prion protein. J. Neurosci. 1999, 19(20):8866-8875.
56. Hill A.F., Antoniou M., Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 1999, 80(Pt 1):11-14.
57. Horiuchi M., Yamazaki N., Ikeda T., Ishiguro N., Shinagawa M. A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep. J. Gen. Virol. 1995, 76(Pt 10):2583-2587.
58. Iba M., Guo J.L., McBride J.D., Zhang B., Trojanowski J.Q., Lee V.M. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J. Neurosci. 2013, 33(3):1024-1037.
59. Imran M., Mahmood S. An overview of animal prion diseases. Virol. J. 2011, 8:493.
60. Jarrett J.T., Lansbury P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 1993, 73(6):1055-1058.
61. Khosravani H., Zhang Y., Tsutsui S., Hameed S., Altier C., Hamid J., Chen L., Villemaire M., Ali Z., Jirik F.R., Zamponi G.W. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Cell Biol. 2008, 181(3):551-565.
62. Kocisko D.A., Come J.H., Priola S.A., Chesebro B., Raymond G.J., Lansbury P.T., Caughey B. Cell-free formation of protease-resistant prion protein. Nature 1994, 370(6489):471-474.
63. Kordower J.H., Chu Y., Hauser R.A., Freeman T.B., Olanow C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 2008, 14(5):504-506.
64. Kumar J., Sreeramulu S., Schmidt T.L., Richter C., Vonck J., Heckel A., Glaubitz C., Schwalbe H. Prion protein amyloid formation involves structural rearrangements in the C-terminal domain. Chembiochem 2010, 11(9):1208-1213.
65. Lashuel H.A., Overk C.R., Oueslati A., Masliah E. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 2013, 14(1):38-48.
66. Legname G., Baskakov I.V., Nguyen H.O., Riesner D., Cohen F.E., DeArmond S.J., Prusiner S.B. Synthetic mammalian prions. Science 2004, 305(5684):673-676.
67. Legname G., Giachin G., Benetti F. Structural studies of prion proteins and prions. Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases 2012, 289-317. Springer, Netherlands. F. Rahimi, G. Bitan (Eds.).
68. Legname G., Nguyen H.O., Baskakov I.V., Cohen F.E., Dearmond S.J., Prusiner S.B. Strain-specified characteristics of mouse synthetic prions. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(6):2168-2173.
69. Legname G., Nguyen H.O., Peretz D., Cohen F.E., DeArmond S.J., Prusiner S.B. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(50):19105-19110.
70. Legname G., Zanusso G. Molecular pathogenesis of prion diseases. Miscellanea on Encephalopathies 2012, 95-112. InTech. R. Tanasescu (Ed.).
71. Li J.Y., Englund E., Holton J.L., Soulet D., Hagell P., Lees A.J., Lashley T., Quinn N.P., Rehncrona S., Bjorklund A., Widner H., Revesz T., Lindvall O., Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 2008, 14(5):501-503.
72. Liu L., Drouet V., Wu J.W., Witter M.P., Small S.A., Clelland C., Duff K. Trans-synaptic spread of tau pathology in vivo. PLoS ONE 2012, 7(2):e31302.
73. Luk K.C., Kehm V., Carroll J., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338(6109):949-953.
74. Luk K.C., Kehm V.M., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J. Exp. Med. 2012, 209(5):975-986.
75. Luk K.C., Song C., O'Brien P., Stieber A., Branch J.R., Brunden K.R., Trojanowski J.Q., Lee V.M. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(47):20051-20056.
76. Maglio L.E., Perez M.F., Martins V.R., Brentani R.R., Ramirez O.A. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res. Mol. Brain Res. 2004, 131(1-2):58-64.
77. Makarava N., Kovacs G.G., Bocharova O., Savtchenko R., Alexeeva I., Budka H., Rohwer R.G., Baskakov I.V. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol. 2010, 119(2):177-187.
78. Marijanovic Z., Caputo A., Campana V., Zurzolo C. Identification of an intracellular site of prion conversion. PLoS Pathog. 2009, 5(5):e1000426.
79. Masuda-Suzukake M., Nonaka T., Hosokawa M., Oikawa T., Arai T., Akiyama H., Mann D.M., Hasegawa M. Prion-like spreading of pathological alpha-synuclein in brain. Brain 2013, 136(Pt 4):1128-1138.
80. McGuire L.I., Peden A.H., Orru C.D., Wilham J.M., Appleford N.E., Mallinson G., Andrews M., Head M.W., Caughey B., Will R.G., Knight R.S., Green A.J. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 2012, 72(2):278-285.
81. Meyer-Luehmann M., Coomaraswamy J., Bolmont T., Kaeser S., Schaefer C., Kilger E., Neuenschwander A., Abramowski D., Frey P., Jaton A.L., Vigouret J.M., Paganetti P., Walsh D.M., Mathews P.M., Ghiso J., Staufenbiel M., Walker L.C., Jucker M. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006, 313(5794):1781-1784.
82. Moda F., Gambetti P., Notari S., Concha-Marambio L., Catania M., Park K.W., Maderna E., Suardi S., Haik S., Brandel J.P., Ironside J., Knight R., Tagliavini F., Soto C. Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N. Engl. J. Med. 2014, 371(6):530-539.
83. Morales R., Duran-Aniotz C., Castilla J., Estrada L.D., Soto C. De novo induction of amyloid-beta deposition in vivo. Mol. Psychiatry 2012, 17(12):1347-1353.
84. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., Kellermann O. Signal transduction through prion protein. Science 2000, 289(5486):1925-1928.
85. Munch C., O'Brien J., Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(9):3548-3553.
86. Narkiewicz J., Giachin G., Legname G. In vitro aggregation assays for the characterization of alpha-synuclein prion-like properties. Prion 2014, 8(1).
87. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314(5796):130-133.
88. Nonaka T., Watanabe S.T., Iwatsubo T., Hasegawa M. Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. J. Biol. Chem. 2010, 285(45):34885-34898.
89. Orru C.D., Bongianni M., Tonoli G., Ferrari S., Hughson A.G., Groveman B.R., Fiorini M., Pocchiari M., Monaco S., Caughey B., Zanusso G. A test for Creutzfeldt-Jakob disease using nasal brushings. N. Engl. J. Med. 2014, 371(6):519-529.
90. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(23):10962-10966.
91. Pastrana M.A., Sajnani G., Onisko B., Castilla J., Morales R., Soto C., Requena J.R. Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 2006, 45(51):15710-15717.
92. Poggiolini I., Saverioni D., Parchi P. Prion protein misfolding, strains, and neurotoxicity: an update from studies on mammalian prions. Int. J. Cell Biol. 2013, 2013:910314.
93. Polymenidou M., Cleveland D.W. The seeds of neurodegeneration: prion-like spreading in ALS. Cell 2011, 147(3):498-508.
94. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216(4542):136-144.
95. Prusiner S.B. Molecular biology of prion diseases. Science 1991, 252(5012):1515-1522.
96. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(23):13363-13383.
97. Pushie M.J., Pickering I.J., Martin G.R., Tsutsui S., Jirik F.R., George G.N. Prion protein expression level alters regional copper, iron and zinc content in the mouse brain. Metallomics 2011, 3(2):206-214.
98. Requena J.R., Wille H. The structure of the infectious prion protein: experimental data and molecular models. Prion 2014, 8(1).
99. Rey N.L., Petit G.H., Bousset L., Melki R., Brundin P. Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol. 2013, 126(4):555-573.
100. Ridley R.M., Baker H.F., Windle C.P., Cummings R.M. Very long term studies of the seeding of beta-amyloidosis in primates. J. Neural Transm. 2006, 113(9):1243-1251.
101. Roberts K., Zeineddine R., Corcoran L., Li W., Campbell I.L., Yerbury J.J. Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. Glia 2013, 61(3):409-419.
102. Rouvinski A., Karniely S., Kounin M., Moussa S., Goldberg M.D., Warburg G., Lyakhovetsky R., Papy-Garcia D., Kutzsche J., Korth C., Carlson G.A., Godsave S.F., Peters P.J., Luhr K., Kristensson K., Taraboulos A. Live imaging of prions reveals nascent PrPSc in cell-surface, raft-associated amyloid strings and webs. J. Cell Biol. 2014, 204(3):423-441.
103. Ruan Y., Zheng X.Y., Zhang H.L., Zhu W., Zhu J. Olfactory dysfunctions in neurodegenerative disorders. J. Neurosci. Res. 2012, 90(9):1693-1700.
104. Saborio G.P., Permanne B., Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001, 411(6839):810-813.
105. Sacino A.N., Brooks M., McGarvey N.H., McKinney A.B., Thomas M.A., Levites Y., Ran Y., Golde T.E., Giasson B.I. Induction of CNS alpha-synuclein pathology by fibrillar and non-amyloidogenic recombinant alpha-synuclein. Acta Neuropathol. Commun. 2013, 1(1):38.
106. Safar J., Wille H., Itrri V., Groth D., Serban H., Torchia M., Cohen F.E., Prusiner S.B. Eight prion strains have PrPSc molecules with different conformations. Nat. Med. 1998, 4(10):1157-1165.
107. Salvadores N., Shahnawaz M., Scarpini E., Tagliavini F., Soto C. Detection of misfolded Abeta oligomers for sensitive biochemical diagnosis of Alzheimer's disease. Cell Rep. 2014, 7(1):261-268.
108. Sanders D.W., Kaufman S.K., DeVos S.L., Sharma A.M., Mirbaha H., Li A., Barker S.J., Foley A.C., Thorpe J.R., Serpell L.C., Miller T.M., Grinberg L.T., Seeley W.W., Diamond M.I. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 2014, 82(6):1271-1288.
109. Santuccione A., Sytnyk V., Leshchyns'ka I., Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J. Cell Biol. 2005, 169(2):341-354.
110. Serpell L.C., Berriman J., Jakes R., Goedert M., Crowther R.A. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(9):4897-4902.
111. Smirnovas V., Baron G.S., Offerdahl D.K., Raymond G.J., Caughey B., Surewicz W.K. Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat. Struct. Mol. Biol. 2011, 18(4):504-506.
112. Solassol J., Crozet C., Lehmann S. Prion propagation in cultured cells. Br. Med. Bull. 2003, 66:87-97.
113. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(11):6469-6473.
114. Steele A.D., Emsley J.G., Ozdinler P.H., Lindquist S., Macklis J.D. Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(9):3416-3421.
115. Stohr J., Condello C., Watts J.C., Bloch L., Oehler A., Nick M., DeArmond S.J., Giles K., DeGrado W.F., Prusiner S.B. Distinct synthetic Abeta prion strains producing different amyloid deposits in bigenic mice. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(28):10329-10334.
116. Stohr J., Watts J.C., Mensinger Z.L., Oehler A., Grillo S.K., DeArmond S.J., Prusiner S.B., Giles K. Purified and synthetic Alzheimer's amyloid beta (Abeta) prions. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(27):11025-11030.
117. Tanaka M., Chien P., Naber N., Cooke R., Weissman J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 2004, 428(6980):323-328.
118. Tycko R., Savtchenko R., Ostapchenko V.G., Makarava N., Baskakov I.V. The alpha-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel beta-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry 2010, 49(44):9488-9497.
119. Tycko R., Wickner R.B. Molecular structures of amyloid and prion fibrils: consensus versus controversy. Acc. Chem. Res. 2013, 46(7):1487-1496.
120. Tzaban S., Friedlander G., Schonberger O., Horonchik L., Yedidia Y., Shaked G., Gabizon R., Taraboulos A. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002, 41(42):12868-12875.
121. Sc. International Prion Congress-Prion, vol. 8 2014, 6.
122. Vilette D. Cell models of prion infection. Vet. Res. 2008, 39(4):10.
123. Volpicelli-Daley L.A., Luk K.C., Patel T.P., Tanik S.A., Riddle D.M., Stieber A., Meaney D.F., Trojanowski J.Q., Lee V.M. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011, 72(1):57-71.
124. Wang F., Wang X., Ma J. Conversion of bacterially expressed recombinant prion protein. Methods 2011, 53(3):208-213.
125. Wang F., Wang X., Yuan C.G., Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010, 327(5969):1132-1135.
126. Wang F., Yang F., Hu Y., Wang X., Jin C., Ma J. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. Biochemistry 2007, 46(23):7045-7053.
127. Wang F., Zhang Z., Wang X., Li J., Zha L., Yuan C.G., Weissmann C., Ma J. Genetic informational RNA is not required for recombinant prion infectivity. J. Virol. 2012, 86(3):1874-1876.
128. Watts J.C., Condello C., Stohr J., Oehler A., Lee J., DeArmond S.J., Lannfelt L., Ingelsson M., Giles K., Prusiner S.B. Serial propagation of distinct strains of Abeta prions from Alzheimer's disease patients. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(28):10323-10328.
129. Watts J.C., Giles K., Oehler A., Middleton L., Dexter D.T., Gentleman S.M., DeArmond S.J., Prusiner S.B. Transmission of multiple system atrophy prions to transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(48):19555-19560.
130. White S.H., Ladokhin A.S., Jayasinghe S., Hristova K. How membranes shape protein structure. J. Biol. Chem. 2001, 276(35):32395-32398.
131. Wilham J.M., Orru C.D., Bessen R.A., Atarashi R., Sano K., Race B., Meade-White K.D., Taubner L.M., Timmes A., Caughey B. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 2010, 6(12):e1001217.
132. Wille H., Bian W., McDonald M., Kendall A., Colby D.W., Bloch L., Ollesch J., Borovinskiy A.L., Cohen F.E., Prusiner S.B., Stubbs G. Natural and synthetic prion structure from X-ray fiber diffraction. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(40):16990-16995.
133. Wiltzius J.J., Landau M., Nelson R., Sawaya M.R., Apostol M.I., Goldschmidt L., Soriaga A.B., Cascio D., Rajashankar K., Eisenberg D. Molecular mechanisms for protein-encoded inheritance. Nat. Struct. Mol. Biol. 2009, 16(9):973-978.
134. Yamasaki T., Baron G.S., Suzuki A., Hasebe R., Horiuchi M. Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells. Virology 2014, 450-451:324-335.
135. Zahn R., Liu A., Luhrs T., Riek R., von Schroetter C., Lopez Garcia F., Billeter M., Calzolai L., Wider G., Wuthrich K. NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(1):145-150.
136. Zanusso G., Ferrari S., Cardone F., Zampieri P., Gelati M., Fiorini M., Farinazzo A., Gardiman M., Cavallaro T., Bentivoglio M., Righetti P.G., Pocchiari M., Rizzuto N., Monaco S. Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N. Engl. J. Med. 2003, 348(8):711-719.
137. Zhang Z., Zhang Y., Wang F., Wang X., Xu Y., Yang H., Yu G., Yuan C., Ma J. De novo generation of infectious prions with bacterially expressed recombinant prion protein. FASEB J. 2013, 27(12):4768-4775.
138. Zou W.-Q., Gambetti P., Xiao X., Yuan J., Langeveld J., Pirisinu L. Prions in variably protease-sensitive prionopathy: an update. Pathogens 2013, 2(3):457-471.